Clinical Trial Update: Efficacy and Safety of TwHF and MTX in Patients With Rheumatoid Arthritis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the efficacy and safety of Tripterygium wilfordii Hook F (TwHF) in combination with methotrexate for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Tripterygium wilfordii Hook F (TwHF) (Tripterygium wilfordii Hook F)

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: UNKNOWN